“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Monday, August 25, 2025

Radius Health


Radius Health – Product Catalog (A–Z)

  • Abaloparatide (TYMLOS) → Generic: abaloparatide (parathyroid hormone-related protein analog) → Indication: Postmenopausal women and men at high risk for osteoporotic fracture → Dose: Prefilled injector, 80 mcg subcutaneous once daily

  • Elacestrant (ORSERDU) → Generic: elacestrant (oral selective estrogen receptor degrader, SERD) → Indication: ER+/HER2–, ESR1-mutated advanced or metastatic breast cancer (post-endocrine therapy) → Dose: Oral tablets 345 mg once daily

  • RAD1901 (developmental, same as elacestrant) → Generic: elacestrant → Indication: Breast cancer (now marketed as Orserdu) → Dose: Clinical trial doses 200–500 mg

  • RAD011 (pipeline) → Generic: cannabidiol oral solution → Indication: Ultra-rare pediatric epilepsies (Dravet syndrome, Lennox–Gastaut syndrome, etc.) → Dose: Oral solution 100 mg/mL (investigational)

  • TYMLOS Pen → Generic: abaloparatide injector device → Indication: Osteoporosis self-injection system → Dose: Device delivering 80 mcg daily


    • on

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)